Key result
The nicotine metabolite ratio (NMR) is a validated biomarker for personalizing smoking cessation treatment, with further research needed on its application in diverse populations and e-cigarettes.
Why the study?
To summarize evidence on the nicotine metabolite ratio as a biomarker of nicotine metabolism and evaluate its clinical utility in personalizing smoking cessation treatments.
Does using the nicotine metabolite ratio (NMR) as a biomarker improve personalized smoking cessation treatment outcomes in smokers?
Design
Review
Authors
Loading...
NMR may aid personalized cessation pharmacotherapy in select patients; leaves open broader validation across populations and e-cigarettes.
Does using the nicotine metabolite ratio (NMR) as a biomarker improve personalized smoking cessation treatment outcomes in smokers?
The nicotine metabolite ratio (NMR) serves as a validated, genetically informed biomarker that can personalize and improve smoking cessation treatments.
Siegel et al. (2020) conducted a review in Smoking cessation. Nicotine metabolite ratio (NMR) was evaluated. The nicotine metabolite ratio (NMR) is a validated biomarker for personalizing smoking cessation treatment, with further research needed on its application in diverse populations and e-cigarettes.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: